181 related articles for article (PubMed ID: 24232445)
1. The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder.
Grobler AC; Matthews G; Molenberghs G
Psychopharmacology (Berl); 2014 May; 231(9):1987-99. PubMed ID: 24232445
[TBL] [Abstract][Full Text] [Related]
2. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
[TBL] [Abstract][Full Text] [Related]
3. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
Sarris J; Fava M; Schweitzer I; Mischoulon D
Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
5. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
7. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
Bitran S; Farabaugh AH; Ameral VE; LaRocca RA; Clain AJ; Fava M; Mischoulon D
Int Clin Psychopharmacol; 2011 Jul; 26(4):206-12. PubMed ID: 21278577
[TBL] [Abstract][Full Text] [Related]
8. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
9. Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group.
Chen JA; Vijapura S; Papakostas GI; Parkin SR; Kim DJ; Cusin C; Baer L; Clain AJ; Fava M; Mischoulon D
Asian J Psychiatr; 2015 Feb; 13():23-9. PubMed ID: 25544195
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Solomon D; Adams J; Graves N
J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
[TBL] [Abstract][Full Text] [Related]
11. St John's wort for major depression.
Linde K; Berner MM; Kriston L
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD000448. PubMed ID: 18843608
[TBL] [Abstract][Full Text] [Related]
12. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
13. St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
15. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
16. St John's wort for depression: meta-analysis of randomised controlled trials.
Linde K; Berner M; Egger M; Mulrow C
Br J Psychiatry; 2005 Feb; 186():99-107. PubMed ID: 15684231
[TBL] [Abstract][Full Text] [Related]
17. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
19. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
20. St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study.
Kobak KA; Taylor LV; Bystritsky A; Kohlenberg CJ; Greist JH; Tucker P; Warner G; Futterer R; Vapnik T
Int Clin Psychopharmacol; 2005 Nov; 20(6):299-304. PubMed ID: 16192837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]